Ask the Experts: Hematology-Oncology
Medscape's Ask the Experts allows you to ask members of a panel of leading experts for advice or information. You also have the opportunity to share your own views and insights by clicking the "Discuss this" link at the top of each response.
Ask the Experts
- Imatinib and Muscle Cramps: Any Remedies?
- Is Ginseng Effective for Cancer-Related Fatigue?
- Can Mirtazapine Improve Cancer Cachexia Symptoms?
- Is It a HIPAA Violation to Leave Biopsy Results on Voicemail?
- Brand vs Generic Drugs: Are Patient Outcomes Affected?
- High-Dose, Low-Dose, or No-Dose Steroid for Weekly Paclitaxel?
- How Can I Help Teens Who Are Victims of Cyberbullying?
- Can the Duration of Aromatase Inhibitor Therapy Exceed 5 Years?
- Avoiding Respiratory Depression With Opiate Use
- Does Selenium Prevent Prostate Cancer?
- Why Must Doxil® Be Administered by IV Infusion?
- What Should Patients Do With Unused Narcotics?
- Do Blood Transfusions Affect the INR?
- How Should I Manage Patients With Sickle Cell Anemia and Hepatitis C?
- What Risk Factors Are Associated With Antithyroid Drug-Induced Agranulocytosis?
- Can Opioid Tolerance Be Treated by Increasing the Opioid Dose?
- Endoscopic Eradication Therapy for Barrett's Esophagus
- What Type of Care Is Required for the Post-Splenectomy Patient?
- Am I Ready for Residency?
- What Antibiotic Covers MSSA Infection?
Disclaimer
The information in this web site reflects the views of the authors only and not Medscape. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or utilizing any therapies noted in this program.
Expert Panel
Harold J. Burstein, MD, PhD, Assistant Professor, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.
Avraham Eisbruch, MD, Professor of Radiation Oncology, University of Michigan, and Clinical Division Director, University of Michigan Hospital, Ann Arbor, MI.
John D. Hainsworth, MD, Director, Clinical Research, Sarah Cannon Cancer Center, Nashville, Tennessee.
Manuel Hidalgo, MD, Associate Professor, Director, Johns Hopkins University, Baltimore, Maryland.
Clifford Hudis, MD, Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Associate Professor of Medicine, Joan and Sanford I. Weill Medical College, Cornell University, New York, NY.
Corey J. Langer, MD, Associate Professor of Medicine, Temple University, Philadelphia, Pennsylvania; Medical Director, Thoracic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
John S. Macdonald, MD, Professor of Medicine, New York Medical College, Valhalla, New York; Chief, Gastrointestinal Oncology Service, St. Vincent's Catholic Medical Center-Manhattan, New York, NY.
Marshall Posner, MD, Associate Professor of Medicine, Adult Oncology; Medical Director, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Kathleen I. Pritchard, MD, FRCPC, Head, Clinical Trials and Epidemiology, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada; Clinical Director, Ontario Clinical Oncology Group, Toronto, Ontario, Canada.
Joseph A. Sparano, MD, Professor of Medicine, Albert Einstein College of Medicine, Bronx, New York; Director, Breast Evaluation Center, Montefiore-Einstein Cancer Center, Bronx, New York.
Paul A. Vasey MSc, MD, MRCP, Senior Lecturer in Medical Oncology and Honorary Consultant Cancer Physician, Cancer Research Campaign Department of Medical Oncology, University of Glasgow and Beatson Oncology Centre, Glasgow, Scotland, UK.